Colomiere et al. suggested the existence of post-receptor defects in the insulin signaling pathway in placentas from GDM treated with diet vs. insulin, although the limited number of subjects of that study (less than 10) could limit relevance of the results [14]. The gene discussed is INS; the disease is gestational diabetes.